Why NNMT Appears at the Frontier of Both Cancer and Obesity Research
The same 29 kDa cytosolic enzyme is used by tumors to rewrite epigenetics and by adipose tissue to link with obesity. This article dissects the mechanism evidence and translational progress of NNMT along both disease lines.
- Recent Advances
- Product Information
Recent Advances
Abstract: The same 29 kDa cytosolic enzyme is used by tumors to rewrite epigenetics and by adipose tissue to link with obesity. This article dissects the mechanism evidence and translational progress of NNMT along both disease lines.
Keywords: NNMT,Cancer metabolism,1-MNA,Obesity,Insulin resistance,Epigenetics,UA085039
Note: The full article is published in Chinese. Please refer to the Chinese version for complete experimental details, figures and product references. For product inquiries, visit www.ua-bio.com.
Product Information













